{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:58:14Z","timestamp":1793861894771,"version":"4.6.1"},"reference-count":12,"publisher":"Massachusetts Medical Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEJM Evidence"],"published-print":{"date-parts":[[2023,3,28]]},"DOI":"10.1056\/evidoa2200239","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T12:00:12Z","timestamp":1679486412000},"source":"Crossref","is-referenced-by-count":133,"title":["Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma"],"prefix":"10.1056","volume":"2","author":[{"given":"Georgina V.","family":"Long","sequence":"first","affiliation":[{"name":"Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Stephen Hodi","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan J.","family":"Lipson","sequence":"additional","affiliation":[{"name":"Bloomberg\u223cKimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospital Essen, Essen, Germany"},{"name":"German Cancer Consortium, Partner Site Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo A.","family":"Ascierto","sequence":"additional","affiliation":[{"name":"Istituto Nazionale Tumori IRCCS \u201cFondazione G. Pascale,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Matamala","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Salman","sequence":"additional","affiliation":[{"name":"Department of Oncology, Instituto Oncol\u00f3gico Fundaci\u00f3n Arturo L\u00f3pez P\u00e9rez, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Castillo Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"FAICIC Clinical Research, Veracruz, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Maria Sk\u0142odowska-Curie National Research Institute of Oncology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Gogas","sequence":"additional","affiliation":[{"name":"Department of Medicine, National and Kapodistrian University of Athens, Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Lao","sequence":"additional","affiliation":[{"name":"Michigan Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Janoski De Menezes","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora da Concei\u00e7\u00e3o, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Dalle","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, Hospices Civils de Lyon, Cancer Research Center of Lyon, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Arance","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital Clinic Barcelona and IDIBAPS, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Grob","sequence":"additional","affiliation":[{"name":"Aix-Marseille University, CHU Timone, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Keidel","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anadil","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Sobiesk","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Dolfi","sequence":"additional","affiliation":[{"name":"Bristol Myers Squibb, Princeton, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein A.","family":"Tawbi","sequence":"additional","affiliation":[{"name":"Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02229"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00233"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503093"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30274-8"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.1422"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1249561"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109970"},{"key":"e_1_3_5_12_2","unstructured":"U.S. Food & Drug Administration. FDA approves Opdualag for unresectable or metastatic melanoma. March 21 2022 (https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-opdualag-unresectable-or-metastatic-melanoma)."},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.911"}],"container-title":["NEJM Evidence"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T09:30:23Z","timestamp":1682415023000},"score":1,"resource":{"primary":{"URL":"https:\/\/evidence.nejm.org\/doi\/10.1056\/EVIDoa2200239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,3,28]]}},"alternative-id":["10.1056\/EVIDoa2200239"],"URL":"https:\/\/doi.org\/10.1056\/evidoa2200239","relation":{},"ISSN":["2766-5526"],"issn-type":[{"value":"2766-5526","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}